Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • Uncategorized

Category: Uncategorized

Discover the latest updates and diverse insights across various topics at Med Pharma News. Stay informed with breaking news, in-depth analyses, and exclusive reports covering a wide spectrum of subjects relevant to the pharmaceutical and healthcare industries.

roche fenebrutinib fda priority review ms
  • Uncategorized

FDA Accepts Roche’s Fenebrutinib NDA with Priority Review for Relapsing and Primary Progressive MS

Megan Wood1 week ago8 hours ago012 mins

Fenebrutinib priority review: the FDA accepted Roche’s NDA for the BTK inhibitor in relapsing and primary progressive MS, announced 30 September 2026.

Read More

Categories

  • Healthcare IT (14)
  • Industry Insights (297)
  • Lifestyle and Wellness (21)
  • Medical Devices (18)
  • Pharmaceuticals (38)
  • Uncategorized (1)

Recent Posts

  • New York Governor to Seek Federal Help on Measles Outbreak
  • Kennedy Launches New Push on Vaccine Injuries: What HHS Revealed
  • City Therapeutics Eyes Valuation of Up to $956.3 Million in US IPO
  • Teva Wins FDA Approval for Monthly Schizophrenia Injection Weltruza
  • WHO Launches Global Roadmap to Tackle Hypertension in Pregnancy
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.